Tompkins Financial’s Boston Scientific BSX Stock Holding History

Tompkins Financial’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-111	Closed	-$10.6K	–	578
2025 Q4	$10.6K	Hold	111	–	–	﹤0.01%	437
2025 Q3	$10.8K	Hold	111	–	–	﹤0.01%	436
2025 Q2	$11.9K	Hold	111	–	–	﹤0.01%	429
2025 Q1	$11.2K	Buy	+111	New	+$11.2K	﹤0.01%	438
2024 Q3	–	Sell	-9,429	Closed	-$726K	–	587
2024 Q2	$726K	Hold	9,429	–	–	0.08%	107
2024 Q1	$646K	Hold	9,429	–	–	0.07%	116
2023 Q4	$545K	Buy	+9,429	New	+$503K	0.07%	124
2021 Q4	–	Sell	-53	Closed	-$2K	–	353
2021 Q3	$2K	Buy	+53	New	+$2.35K	﹤0.01%	369
2021 Q1	$2K	Hold	53	–	–	﹤0.01%	408
2020 Q4	$2K	Buy	+53	New	+$1.91K	﹤0.01%	420
2020 Q3	–	Sell	-112	Closed	-$4K	–	385
2020 Q2	$4K	Buy	+112	New	+$4.03K	﹤0.01%	352
2018 Q3	–	Sell	-1,000	Closed	-$33K	–	428
2018 Q2	$33K	Buy	+1,000	New	+$30.2K	0.01%	289

Other funds holding BSX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Tompkins Financial's BSX Position: Q1 2026 in Review

Tompkins Financial sold out of Boston Scientific (BSX) in Q1 2026, closing a stake of 111 shares — an estimated $10.6K sold.

Tompkins Financial first reported a position in BSX in Q2 2018 and held it in 12 quarters. The position peaked at $726K in Q2 2024. 1,676 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

Tompkins Financial reported no remaining Boston Scientific position as of Q1 2026 after selling out during the quarter.
Tompkins Financial sold 111 Boston Scientific shares in Q1 2026, an estimated $10.6K.
Tompkins Financial first reported a position in Boston Scientific in Q2 2018 and held it in 12 quarters.
Tompkins Financial's Boston Scientific position peaked at $726K in Q2 2024.
1,676 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on Tompkins Financial's 13F filing for Q1 2026, filed 9 Apr 2026.